(PDF) Correction: Polymorphisms at Phase I-Metabolizing

Correction: Polymorphisms at Phase I-Metabolizing Enzyme and Hormone Receptor Loci Influence the Response to Anti-TNF Therapy in Rheumatoid Arthritis Patients

Pharmacogenomics Journal - United Kingdom

doi 10.1038/s41397-019-0084-2

Full Text

Open PDF

Abstract

Available in full text

Date

February 14, 2019

Authors

Luz M. Canet

Jose M. Sánchez-Maldonado

Manuel Martínez-Bueno

Alfonso González-Utrilla

Miguel Ángel López Nevot

Pablo Conesa-Zamora

Alfons den Broeder

Salvatore De Vita

Sven Erik Hobe Jacobsen

Eduardo Collantes-Estevez

Publisher

Springer Science and Business Media LLC

Amanote Research

Correction: Polymorphisms at Phase I-Metabolizing Enzyme and Hormone Receptor Loci Influence the Response to Anti-TNF Therapy in Rheumatoid Arthritis Patients

Pharmacogenomics Journal - United Kingdom

doi 10.1038/s41397-019-0084-2

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients With Rheumatoid Arthritis

Il-4Rα, TNF-α,TNF-α Receptor, and CD4 Enhancer Genes Polymorphisms in Rheumatoid Arthritis Saudi Female Patients

TRAF1/C5 Locus Is Associated With Response to Anti-TNF in Rheumatoid Arthritis

Increasing Levels of Circulating Th17 Cells and Interleukin-17 in Rheumatoid Arthritis Patients With an Inadequate Response to Anti-TNF-Α Therapy

Autoantibody Formation in Patients With Rheumatoid Arthritis Treated With Anti-TNF

Complex Role of TNF Variants in Psoriatic Arthritis and Treatment Response to Anti-TNF Therapy: Evidence and Concepts

Does Anti-TNF Therapy Cause a Less Significant Fall in Bone Mineral Density in Patients With Rheumatoid Arthritis?

Anti-HTVL-I Antibody in Rheumatoid Arthritis Patients in Tsushima.

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-Α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients